James N. Topper - 22 Sep 2022 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Director, 10%+ Owner
Signature
/s/ Larry Miller, Attorney-in-Fact for James Topper
Issuer symbol
PHAT
Transactions as of
22 Sep 2022
Net transactions value
$0
Form type
4
Filing time
26 Sep 2022, 16:09:37 UTC
Previous filing
14 Feb 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHAT Stock Option (Right to Buy Award $0 +20,000 $0.000000 20,000 22 Sep 2022 Common Stock 20,000 $10.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to one-third of the shares of common stock on September 22, 2023, and will vest with respect to the remaining shares in equal monthly installments over the following two years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.